Pharmacy Formulas

A periodical scientific publication, the journal " Formulas of Pharmacy "(hereinafter-the publication), for publishing the main scientific results of dissertations for the degree of candidate of Sciences, for the degree of doctor of Sciences; presents high-quality, peer-reviewed research and interactive clinical content.

Our journal is focused on clinical pharmacologists, specialists of expert organizations, workers centers preclinical and clinical trials of medicinal products; employees of regulatory and Supervisory organizations and institutions in the field of pharmaceutical industry and Russian Ministry of health; researchers, medical and pharmaceutical workers of the organisations and institutions of the Ministry of health; experts of the scientific organizations of RAS and other researchers in the field of environmental security.

The topics of published materials are limited to two branches of science - medical and biological - and they correspond to groups of scientific specialties (03.02.00 General biology, 14.03.00 Biomedical sciences, 14.04.00 Pharmaceutical sciences) in accordance with the order of the Ministry of Education of the Russian Federation dated October 23, 2017 No. 1027 "On the approval of the nomenclature of scientific specialties for which science degrees are awarded" and by order of the Ministry of Education and Science of the Russian Federation of December 12, 2016 No. 1586 (revised March 27, 2018) "On the approval of the rules for forming the list of peer-reviewed scientific publications."

The publication complies with modern rules and requirements of domestic and foreign legislation for peer-reviewed scientific publications.

Journal strategy

When preparing each issue, members of the editorial Board intend to take into account modern requirements for the order of qualified review, information openness and bibliometric indicators in assessing the publication activity of authors, along with other factors of the journal.

To this end, the editorial team uses rigorous: editorial, expert, and statistical review processes to evaluate manuscripts for scientific accuracy, novelty, and importance; policies and practices that ensure that authors disclose all relevant financial associations and that such associations do not in any way affect the content published by the journal.

When developing the strategy and layout of the publication, we studied and analyzed the professional materials available to us from information resources of publishers and owners of bibliographic and abstract databases-leaders of international citation systems for relevant branches of science and groups of scientific specialties.

In the course of this work, three groups of scientific specialties were identified, which, in our opinion, made it possible to create a publication's rubricator and determine its name: "Pharmacy Formulas". At the same time, we took into account the definition of pharmacy as the entire life cycle of medicines, including the creation, preclinical and clinical research, production technology, organization of pharmaceutical business, as well as issues of control and analytical research, food and environmental safety. In turn, the word "formulas" means directions, trends, trends in the development of scientific and practical areas that make up pharmacy.

We believe that through our efforts, the journal will keep healthcare and pharmaceutical industry professionals at the forefront of medical and pharmaceutical knowledge, help them deepen their understanding of new areas of interest, and provide valuable insights into scientific and practical medical and pharmaceutical activities.

Authors and readers

To present the results of high-quality scientific research to the reader, we are ready to be responsible for preparing the manuscript to meet the requirements of the journal, quality review of manuscripts , preparing the article for publication, providing opportunities and scientific communications of the founders of the publication to promote the article.

The journal's website meets all the requirements of the international bibliographic database. Full electronic document flow for authors, reviewers, scientific and literary editors is carried out on our own platform.

To promote the article, authors will be able to use the personal website of the publication; assignment of the DOI identifier of the author's manuscript immediately after uploading to the site; unique author ID ORCID; professional social networks Google Scholar, ResearchGate; repositories; open electronic archives; bibliography management system; social media; registration of the scientist as a reviewer; assistance in preparing the use of media (materials for press releases, interviews).

The publishing house of the journal has direct channels for transmitting information to the RSCI and international databases: Scopus, Web of Science, PubMed, CNKI.

When developing all the tasks facing the members of the editorial Board and editorial Board of the journal "Formulas of Pharmacy", we share a common goal: to promote and actively participate in scientific communications on the declared groups of scientific specialties in the biomedical field and pharmacy, from the idea to the release of medicines to the consumer market and management of their waste and metabolites.


No announcements have been published.
More Announcements...

Favorite articles


Current Issue

Vol 5, No 1 (2023)

Pharmaceutical Sciences

Candidiasis: the problem of finding new etiotropic drugs among organic synthesis products
Novikova V.V., Gein V.L., Bobrovskaya O.V., Pulina N.A., Igidov N.M., Rudakova I.P.

1043 compounds - products of organic synthesis were screened for antifungal activity on the type strain C. albicans NCTC 885-653 in planktonic culture. In-depth studies of substances with high activity against typical strains of Candida spp. and clinical isolates to identify lead compounds, including on a biofilm model were done. 3 substances were identified that exhibit high antifungal activity (MIC50 - 1.0-2.0; MIC90 - 7.8-31.2), exceeding the effect of the reference drug fluconazole. Thus, representatives of new chemical groups with antifungal activity were identified. A methodology has been developed for searching for compounds with antifungal activity among products of organic synthesis, based on the use of a combination of theoretical, physicochemical, and biological methods. An algorithm for the early stages of preclinical studies of the presence of antifungal activity in newly synthesized compounds using microbiological methods is proposed. It including screening studies for typical strains of yeast micromycetes, in-depth studies of clinical isolates to study the cumulative indicators of sensitivity of a population of strains, and determination of the antifungal activity of compounds on a biofilm model.

Pharmacy Formulas. 2023;5(1):10-16
pages 10-16 views

Biomedical Sciences

The state of cancer care in Russia: age and cancer. Features of the localization structure of the quality of accounting and survival of patients with malignant tumors among the child population, adolescents and young adults in Russia (clinical and population study). Part 1
Merabishvili V.M., Shakhzadova A.O., Kulyova S.A., Perelygin V.V.

Currently, there are maximum opportunities for providing specialized oncological care to children and adolescents. Until the late 1980s, the official reporting in the USSR included the registration of cancer patients in the first age group from 0 to 29 years, which included children, adolescents, and young adults. Since 1989, the registration of cancer patients has been carried out in the USSR and Russia according to the recommendations of the International Association of Cancer Registries (IACR) for each five-year age group. However, a new problem emerged - where to classify young adults? In medicine and social sciences, young adults are considered to be individuals who have entered adulthood after the teenage period. Regarding oncology, we need to take into account the specific characteristics of the disease, primarily its structure, which significantly differs among children, adolescents, and young adults. When it comes to studying the specifics of oncopathology in young adults, it was challenging prior to the establishment of a system of population-based cancer registries, considering the relatively rare registration of primary cases of diseases in this population group. The creation of the population-based cancer registry in the Northwestern Federal District of Russia in 2019, serving a population of 13.9 million people – more than the combined population of Belarus, Latvia, and Estonia – provides unique opportunities to address the complex issues for this age group. This registry enables us not only to thoroughly examine the specific localization structure but also to calculate survival rates according to international standards.

Pharmacy Formulas. 2023;5(1):20-32
pages 20-32 views

Biological sciences

The Majestic Landscape of the Eukaryotic Megasystematics
Strugar Y.V., Tomusjak M.V.

In December 2022, a team of authors prepared and published in the English version the monograph “Nomenclature and rank correlation of higher taxa of eukaryotes”, dedicated to a review of higher taxa of eukaryotes and solving the problem of their rank correlation. The introductory part of the work shows significant milestones in the history of eukaryotic megasystematics, whereas the methodological part discusses the principles and approaches to the nomenclature of the higher taxa of this domain. The authors carried out a revision of the system of eukaryotic organisms with references to the original descriptions of the corresponding taxa, considered the trends in the transformation of the system, and discussed issues of its practical application. The book contains descriptions of the subdomain Obimoda, the kingdom Crumalia, and the phyla Mantamonadea, Rigifilidea, and Collodictyonidea. The monograph crowned with a retrospective summary of the main eukaryotic systems published in the period 1925–2022 and an extensive list of papers on megasystematics and microbiology of eukaryotes. The present review is devoted to the evaluation of this theoretically and practically important work.

Pharmacy Formulas. 2023;5(1):34-39
pages 34-39 views

Pharmaceutical learning activit

Modern technologies for diagnosis and treatment of eye diseases
Tyukavin A.I., Solomennikov A.V., Umarov S.Z.

The lecture covers the morphofunctional organization of the visual sensory system. The structure of the visual organ is presented, with particular attention given to the eye structures responsible for conducting and perceiving visible light. The peculiarities of the eye’s optical system and the mechanisms of the formation and circulation of aqueous humor in the eye are discussed. The prevalence of eye diseases is shown, and the most relevant types of pathology are identified. Modern high-tech diagnostic and therapeutic technologies used in conjunctivitis, dry eye syndrome, cataracts, and glaucoma are discussed. Modern individual optical devices for the correction of accommodation disorders in adults and children (glasses, contact lenses, refractive surgery) are also presented.

Pharmacy Formulas. 2023;5(1):40-54
pages 40-54 views

Information and Prevention

New horizons: the company “NIREX” in pursuit of success and development
Kravchenko A.G.

Going back to the origins of medical practice, the use of medical gases has become a key element in ensuring the health and saving the lives of patients. From the use of aromatic oils by ancient civilizations to the availability of medical gas cylinders in modern institutions, medical gases have become an integral part of modern healthcare, playing a crucial role in the diagnosis, treatment and support of patients. By ensuring the safe and efficient functioning of medical institutions throughout Russia, medical gases play a vital role in providing medical workers with the necessary resources to provide quality medical care. Thanks to its experience and expertise, NIREX provides its customers with reliable solutions that ensure accurate dosage and proper control of gases such as oxygen, nitrogen, air and much more.

Pharmacy Formulas. 2023;5(1):56-59
pages 56-59 views


Alexander Georgievich Egorov was the rector of Leningrad Chemical-Pharmaceutical Institute from 1958 to 1972
Narkevich I.A., Vorobeva S.A., Volgusheva A.O., Perelygin V.V.

Based on unpublished sources from the Central State Archive of Historical and Political Documents of St. Petersburg, as well as from the Central State Archive of St. Petersburg, the biography of Alexander Georgievich Egorov, the rector of the Leningrad Chemical-Pharmaceutical Institute, has been reconstructed. His career in education was extraordinarily successful, which was explained on the one hand by his personal merits, and on the other hand, by his simultaneous rise up the political ladder, which was a tribute to the times and characterized the Soviet system as a whole. The authors consider Alexander Georgievich’s contribution to the improvement of the structure and personnel of the Leningrad Chemical-Pharmaceutical Institute, the development of scientific work, and the modernization of the institute’s material and technical base. Thanks in large part to the organizational qualities and leadership abilities of Rector A. G. Egorov, during his 12-year leadership, the Leningrad Chemical-Pharmaceutical Institute became known and was the only higher educational institution of its kind, where specialists in the field of pharmacy were trained not only for pharmacies, but also for pharmaceutical factories

Pharmacy Formulas. 2023;5(1):64-72
pages 64-72 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies